{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:09:09Z","timestamp":1771682949772,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12020-019-02047-z","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T15:02:22Z","timestamp":1565622142000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes"],"prefix":"10.1007","volume":"66","author":[{"given":"Rita","family":"Laiginhas","sequence":"first","affiliation":[]},{"given":"Carolina","family":"Madeira","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Barbosa","sequence":"additional","affiliation":[]},{"given":"Vitor","family":"Rosas","sequence":"additional","affiliation":[]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Falc\u00e3o-Reis","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Falc\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"issue":"1","key":"2047_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2015-000161","volume":"4","author":"W-P You","year":"2016","unstructured":"W.-P. You, M. Henneberg, Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Res. Care. 4(1), e000161 (2016). \nhttps:\/\/doi.org\/10.1136\/bmjdrc-2015-000161","journal-title":"BMJ Open Diabetes Res. Care."},{"key":"2047_CR2","unstructured":"International Diabetes Federation. Diabetes Atlas, 8th edn. \nwww.diabetesatlas.org\n\n. 2018. Accessed 8 Aug 2018."},{"issue":"3","key":"2047_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011.Chapter","volume":"39","author":"DM Maahs","year":"2010","unstructured":"D.M. Maahs, N.A. West, J.M. Lawrence, E.J. Mayer-Davis, Chapter 1: epidemiology of type 1 diabetes. Endocrinol. Metab. Clin. North Am. 39(3), 481\u2013497 (2010). \nhttps:\/\/doi.org\/10.1016\/j.ecl.2010.05.011.Chapter","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"2047_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1591-y","volume":"15","author":"PA Diaz-Valencia","year":"2015","unstructured":"P.A. Diaz-Valencia, P. Bougn\u00e8res, A.-J. Valleron, Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 15(1), 255 (2015). \nhttps:\/\/doi.org\/10.1186\/s12889-015-1591-y","journal-title":"BMC Public Health"},{"issue":"2","key":"2047_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"N.J. Thomas, S.E. Jones, M.N. Weedon, B.M. Shields, R.A. Oram, A.T. Hattersley, Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 6(2), 122\u2013129 (2018). \nhttps:\/\/doi.org\/10.1016\/S2213-8587(17)30362-5","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2047_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.arcmed.2017.10.003","volume":"48","author":"T Bulum","year":"2017","unstructured":"T. Bulum, M. Tomic, L. Duvnjak, Total serum cholesterol increases risk for development and progression of nonproliferative retinopathy in patients with type 1 diabetes without therapeutic intervention: Prospective, Observational Study. Arch. Med Res. 48(5), 467\u2013471 (2017). \nhttps:\/\/doi.org\/10.1016\/j.arcmed.2017.10.003","journal-title":"Arch. Med Res."},{"issue":"9","key":"2047_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/archophthalmol.2012.1800","volume":"130","author":"JE Grunwald","year":"2012","unstructured":"J.E. Grunwald, J. Alexander, G.-S. Ying, et al., Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch. Ophthalmol. (Chic., Ill. 1960). 130(9), 1136\u20131144 (2012). \nhttps:\/\/doi.org\/10.1001\/archophthalmol.2012.1800","journal-title":"Arch. Ophthalmol. (Chic., Ill. 1960)."},{"issue":"6","key":"2047_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1755-3768.2009.01742.x","volume":"89","author":"J Mehlsen","year":"2011","unstructured":"J. Mehlsen, M. Erlandsen, P.L. Poulsen, T. Bek, Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol. 89(6), 515\u2013521 (2011). \nhttps:\/\/doi.org\/10.1111\/j.1755-3768.2009.01742.x","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"2047_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.oret.2017.05.014","volume":"2","author":"Douglas A. Stram","year":"2018","unstructured":"D.A. Stram, X. Jiang, R. Varma, et al., Factors associated with prevalent diabetic retinopathy in Chinese Americans: The Chinese American Eye Study. Ophthalmol Retin. 1\u201310. (2017) \nhttps:\/\/doi.org\/10.1016\/j.oret.2017.05.014","journal-title":"Ophthalmology Retina"},{"issue":"5","key":"2047_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/aos.13654","volume":"96","author":"Ragnhild W. Jansson","year":"2018","unstructured":"R.W. Jansson, K.O. Hufthammer, J. Krohn, Diabetic retinopathy in type 1 diabetes patients in Western Norway. Acta Ophthalmol. 1\u201310 (2018) \nhttps:\/\/doi.org\/10.1111\/aos.13654","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"2047_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30521-7","volume":"8","author":"EY-C Kang","year":"2018","unstructured":"E.Y.-C. Kang, F.-S. Lo, J.-P. Wang, et al., Nomogram for prediction of non-proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a cohort study in an Asian population. Sci. Rep. 8(1), 12164 (2018). \nhttps:\/\/doi.org\/10.1038\/s41598-018-30521-7","journal-title":"Sci. Rep."},{"issue":"8","key":"2047_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jdiacomp.2018.05.011","volume":"32","author":"AM Diallo","year":"2018","unstructured":"A.M. Diallo, J.L. Novella, C. Lukas, et al., Early predictors of diabetic retinopathy in type 1 diabetes: The Retinopathy Champagne Ardenne Diab\u00e8te (ReCAD) study. J. Diabetes Complicat. 32(8), 753\u2013758 (2018). \nhttps:\/\/doi.org\/10.1016\/j.jdiacomp.2018.05.011","journal-title":"J. Diabetes Complicat."},{"issue":"4","key":"2047_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ophtha.2016.10.031","volume":"124","author":"SY Wang","year":"2017","unstructured":"S.Y. Wang, C.A. Andrews, W.H. Herman, T.W. Gardner, J.D. Stein, Incidence and risk factors for developing diabetic retinopathy among youths with type 1 or type 2 diabetes throughout the United States. Ophthalmology 124(4), 424\u2013430 (2017). \nhttps:\/\/doi.org\/10.1016\/j.ophtha.2016.10.031","journal-title":"Ophthalmology"},{"issue":"2","key":"2047_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/09286586.2015.1119287","volume":"23","author":"Alan Penman","year":"2016","unstructured":"A. Penman, H. Hancock, E. Papavasileiou, et al., Risk factors for proliferative diabetic retinopathy in african americans with type 2 diabetes risk factors for proliferative diabetic retinopathy in African Americans with. 6586 (2016). \nhttps:\/\/doi.org\/10.3109\/09286586.2015.1119287","journal-title":"Ophthalmic Epidemiology"},{"key":"2047_CR15","doi-asserted-by":"publisher","unstructured":"R.V. Rivera-Virtudazo, A.K.G. Tapia, J.F.B. Valenzuela, L.D. Cruz, H.D. Mendoza, E.V. Castriciones, Lacunarity Analysis of TEM Images of Heat-Treated Hybrid Organosilica Materials. In: Innovations in Chemical Biology. Dordrecht: Springer Netherlands, Dordrechtp. 397\u2013403. \nhttps:\/\/doi.org\/10.1007\/978-1-4020-6955-0_47","DOI":"10.1007\/978-1-4020-6955-0_47"},{"issue":"4","key":"2047_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2337\/dc18-1950","volume":"42","author":"M Nordwall","year":"2019","unstructured":"M. Nordwall, M. Fredriksson, J. Ludvigsson, H.J. Arnqvist, Impact of age of onset, puberty, and glycemic control followed from diagnosis on incidence of retinopathy in type 1 diabetes: The VISS study. Diabetes Care. 42(4), 609\u2013616 (2019). \nhttps:\/\/doi.org\/10.2337\/dc18-1950","journal-title":"Diabetes Care."},{"issue":"10","key":"2047_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/diacare.12.10.686","volume":"12","author":"JN Kostraba","year":"1989","unstructured":"J.N. Kostraba, J.S. Dorman, T.J. Orchard, et al., Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care. 12(10), 686\u2013693 (1989). \nhttps:\/\/doi.org\/10.2337\/diacare.12.10.686","journal-title":"Diabetes Care."},{"issue":"11","key":"2047_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1046\/j.1464-5491.2002.00839.x","volume":"19","author":"C. E. Kullberg","year":"2002","unstructured":"C.E. Kullberg, M. Abrahamsson, H.J. Arnqvist, K. Finnstr\u00f6m, J. Ludvigsson, VISS Study Group. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes. Diabet Med. 19(11):924\u2013931. (2002). \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12421429\n\n. Accessed 29 Aug 2018","journal-title":"Diabetic Medicine"},{"key":"2047_CR19","unstructured":"Census 2011. INE, Instituto Nacional de Estat\u00edstica (Statistics Portugal). (2011) \nhttps:\/\/www.ine.pt\n\n. Accessed 20 Aug 2008."},{"issue":"4","key":"2047_CR20","first-page":"251","volume":"16","author":"Z Jorge","year":"2003","unstructured":"Z. Jorge, E. Lacerda Nobre, A. Macedo, J. J\u00e1comede Castro, Preval\u011bncia da diabetes mellitus tipo 1 em Portugal, 1995-1999: Coorte de jovens do sexo masculino. Acta Med Port. 16(4), 251\u2013253 (2003)","journal-title":"Acta Med Port."},{"issue":"12","key":"2047_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2337\/DIAB.28.12.1039","volume":"28","author":"NDD Group","year":"1979","unstructured":"N.D.D. Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 28(12), 1039\u20131057 (1979). \nhttps:\/\/doi.org\/10.2337\/DIAB.28.12.1039","journal-title":"Diabetes"},{"issue":"14","key":"2047_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group, D.M. Nathan, S. Genuth, et al., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14), 977\u2013986 (1993). \nhttps:\/\/doi.org\/10.1056\/NEJM199309303291401","journal-title":"N. Engl. J. Med."},{"key":"2047_CR23","unstructured":"UKPDS., Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (Lond., Engl.). 352(9131), 837\u2013853 (1998). \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9742976\n\n Accessed 7 Oct 2018."},{"issue":"8","key":"2047_CR24","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00125-011-2198-1","volume":"54","author":"HP Hammes","year":"2011","unstructured":"H.P. Hammes, W. Kerner, S. Hofer, et al., Diabetic retinopathy in type 1 diabetes\u2014a contemporary analysis of 8,784 patients. Diabetologia 54(8), 1977\u20131984 (2011). \nhttps:\/\/doi.org\/10.1007\/s00125-011-2198-1","journal-title":"Diabetologia"},{"issue":"6","key":"2047_CR25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2337\/dc09-2278","volume":"33","author":"K Hietala","year":"2010","unstructured":"K. Hietala, V. Harjutsalo, C. Forsblom, P. Summanen, P.-H. Groop, FinnDiane Study Group on behalf of the FS. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care. 33(6), 1315\u20131319 (2010). \nhttps:\/\/doi.org\/10.2337\/dc09-2278","journal-title":"Diabetes Care."},{"key":"2047_CR26","doi-asserted-by":"publisher","first-page":"9898309","DOI":"10.1155\/2016\/9898309","volume":"2016","author":"L Forga","year":"2016","unstructured":"L. Forga, M.J. Go\u00f1i, B. Ib\u00e1\u00f1ez, K. Cambra, M. Garc\u00eda-Mouriz, A. Iriarte, Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patients with type 1 diabetes. J. Diabetes Res. 2016, 9898309 (2016). \nhttps:\/\/doi.org\/10.1155\/2016\/9898309","journal-title":"J. Diabetes Res."},{"issue":"1","key":"2047_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40842-019-0079-6","volume":"5","author":"N Patel","year":"2019","unstructured":"N. Patel, L. Verchinina, M. Wichorek, et al., Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program. Clin. Diabetes Endocrinol. 5(1), 1\u20138 (2019). \nhttps:\/\/doi.org\/10.1186\/s40842-019-0079-6","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"5","key":"2047_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.oret.2019.01.019","volume":"3","author":"AR Shah","year":"2019","unstructured":"A.R. Shah, A.N. Van Horn, L. Verchinina, et al., Blood Pressure Is Associated with Receiving Intravitreal Anti\u2013Vascular Endothelial Growth Factor Treatment in Patients with Diabetes. Ophthalmol. Retin. 3(5), 410\u2013416 (2019). \nhttps:\/\/doi.org\/10.1016\/j.oret.2019.01.019","journal-title":"Ophthalmol. Retin."},{"issue":"8","key":"2047_CR29","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/aos.13449","volume":"95","author":"MB Larsen","year":"2017","unstructured":"M.B. Larsen, J.E. Henriksen, J. Grauslund, T. Peto, Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark. Acta Ophthalmol. 95(8), 778\u2013786 (2017). \nhttps:\/\/doi.org\/10.1111\/aos.13449","journal-title":"Acta Ophthalmol."},{"key":"2047_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/09286586.2018.1489971","volume":"25","author":"BEK Klein","year":"2018","unstructured":"B.E.K. Klein, K.L. Horak, K.E. Lee, et al., Neural dysfunction and retinopathy in persons with type 1 diabetes. Ophthalmic Epidemiol. 25(5\u20136), 373\u2013378 (2018). \nhttps:\/\/doi.org\/10.1080\/09286586.2018.1489971","journal-title":"Ophthalmic Epidemiol."},{"issue":"7","key":"2047_CR31","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1111\/aos.13733","volume":"96","author":"Berthold Pemp","year":"2018","unstructured":"B. Pemp, S. Palkovits, K. Howorka, et al., Correlation of retinal neurodegeneration with measures of peripheral autonomic neuropathy in type 1 diabetes. Acta Ophthalmol. 96(7), e804\u2013810. (2018). \nhttps:\/\/doi.org\/10.1111\/aos.13733","journal-title":"Acta Ophthalmologica"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-02047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-02047-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-02047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:27:22Z","timestamp":1597102042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-02047-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-02047-z","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}